Clarus Therapeutics to Present at the 2021 Cantor Virtual Global Healthcare Conference
September 22 2021 - 9:05AM
Clarus Therapeutics Holdings, Inc. (Nasdaq:CRXT), a pharmaceutical
company dedicated to providing solutions to unmet medical needs by
advancing androgen and metabolic therapies for men and women, today
announced that it will present at the 2021 Cantor Virtual Global
Healthcare Conference, Monday, September 27, 2021, 10:40 a.m. ET.
The presentation will be webcast live and can be accessed
through the Investors section of Clarus Therapeutics’ website
at Investors.ClarusTherapeutics.com. An archived version of
the webcast will be available approximately two hours following the
live presentation for 90 days.
About Clarus Therapeutics Holdings, Inc. Clarus
Therapeutics Holdings, Inc. is a pharmaceutical company with
expertise in developing androgen and metabolic therapies for men
and women – including potential therapies for orphan indications.
Clarus Therapeutics’ first commercial product is JATENZO®. For more
information, visit www.clarustherapeutics.com and
www.jatenzo.com. Follow us on Twitter (@Clarus_Thera) and LinkedIn
(Clarus Therapeutics).
Clarus Investor Relations Contact:Kara
Stancellkstancell@clarustherapeutics.com(847) 562-4300 x 206
Clarus Therapeutics (NASDAQ:CRXT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Clarus Therapeutics (NASDAQ:CRXT)
Historical Stock Chart
From Apr 2023 to Apr 2024